Sign in
4

Changes in Ownership

HCW Biologics Inc. Filed Acc 0001209191-24-003782

Chief Financial Officer acquired 760,714 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Byam Rebecca Chief Financial Officer 2024-02-20 Grant or award +760,714 $1.40 $1,065,000 1,381,909 D: show line 1 in the form
Loading xslF345X05/doc4.xml…